RIV Capital Inc.

08/28/2024

We're pleased to announce that RIV shareholders have voted in favour to approve the previously announced proposed business combination with Cansortium Inc. Approximately 98.8% of the votes eligible to be cast at the RIV Meeting were voted in favor of the Arrangement Resolution: https://www.rivcapital.com/newsroom/company-news/news-details/2024/08/28/riv-capital-announces-shareholder-approval-of-business-combination-with-cansortium-and-cansortium-announces-shareholder-approval-of-the-amendment-proposal

We also reported our financial results for the quarter ended June 30, 2024. View our results, and catch up on news: https://www.rivcapital.com/newsroom/company-news/news-details/2024/08/28/riv-capital-reports-financial-results-for-the-second-quarter-ended-june-30-2024

Holders of Class A common shares of RIV Capital voted in favor of a special resolution to approve the previously announced proposed business combination with Cansortium Inc

08/21/2024

RIV Capital will report its financial results for the three and six months ended June 30, 2024, before markets open on Wednesday, August 28, 2024.

Info: https://www.rivcapital.com/newsroom/company-news/news-details/2024/08/21/riv-capital-sets-date-for-financial-results-for-second-quarter-ended-june-30-2024

08/19/2024

Today we published an update on the integration activities currently underway in preparation for the completion of our previously announced business combination with Cansortium Inc.

Learn more: https://rivcapital.com/newsroom/company-news/news-details/2024/08/19/riv-capital-and-cansortium-inc.-provide-integration-update-ahead-of-completing-merger

06/25/2024

Today we announced the appointment of David Vautrin as Chief Retail Officer of RIV Capital. A seasoned CPG professional with deep cannabis experience, David will initially oversee retail and wholesale operations in New York 🌿

Appoints Experienced New York and California Cannabis Executive, David Vautrin as Chief Retail Officer to Lead Retail Platform

05/30/2024

Today we also reported our financial results for the first quarter ended March 31, 2024. View the results and catch up on news: https://www.rivcapital.com/newsroom/company-news/news-details/2024/05/30/riv-capital-reports-financial-results-for-the-first-quarter-ended-march-31-2024

05/30/2024

We are pleased to announce that we have entered into a definitive agreement with Cansortium, a vertically integrated, multi-state company with operations in Florida, Pennsylvania, and Texas.

Info: https://www.rivcapital.com/newsroom/company-news/news-details/2024/05/30/cansortium-and-riv-capital-announce-business-combination

04/29/2024

View our latest financial results and catch up on news: https://www.rivcapital.com/newsroom/company-news/news-details/2024/04/29/riv-capital-reports-financial-results-for-the-fiscal-quarter-and-nine-month-transition-period-ended-december-31-2023

During the quarter, Etain Health received New York Cannabis Control Board approval to be one of the first six registered organizations to officially transition to an adult-use license in New York, and Etain has commenced both adult-use retail and wholesale sales.

Ended the year with $81.9 million of cash to support operationalization of New York market and growth initiatives

04/22/2024

RIV Capital will report its financial results for the three months and nine-month transition period ended December 31, 2023, after markets close on Monday, April 29, 2024. Get info: https://www.rivcapital.com/newsroom/company-news/news-details/2024/04/22/riv-capital-sets-date-for-financial-results-for-the-fiscal-quarter-and-nine-month-transition-year-ended-december-31-2023

02/14/2024

Etain Health has opened its first co-located adult-use and medical dispensary in White Plains, New York!
Learn more: https://www.rivcapital.com/newsroom/company-news/news-details/2024/02/14/riv-capital-and-etain-open-first-new-york-adult-use-dispensary-in-white-plains

12/08/2023

Pleased to announce that Etain Health has obtained regulatory approval from the New York Cannabis Control Board to transition to adult-use operations. Read more: https://www.rivcapital.com/newsroom/company-news/news-details/2023/12/08/etain-obtains-approval-to-commence-sales-to-new-york-s-adult-use-market

The Company will now be able to provide its assortment of products, including high-quality flower, pre-rolls, vapes, and edibles, to the adult-use market as well as maintain its medical operations. In addition to expanding into adult-use wholesale operations, the Company anticipates opening its first co-located medical and adult-use retail dispensary in early 2024, followed by two additional co-located adult-use retail dispensaries on or around July 1, 2024.

Receives state regulatory approval from the New York Cannabis Control Board to transition to adult-use operations

11/29/2023

View our latest financial results and catch up on news: https://www.rivcapital.com/newsroom/company-news/news-details/2023/11/29/riv-capital-reports-financial-results-for-the-fiscal-quarter-ended-september-30-2023

We are incredibly proud to share that we submitted our application to transition to an adult-use license in New York. As regulatory progress has accelerated over the last few months, we are confident we will benefit from the favorable position we have established in New York.

Well positioned to execute on opportunities for growth with approximately $85 million in cash at period end

11/15/2023

RIV Capital will report its financial results for the three and six months ended September 30, 2023 before markets open on Wednesday, November 29, 2023.

RIV Capital Inc. will report its financial results for the three and six months ended September 30, 2023 before markets open on Wednesday, November 29, 2023.